Humma Shahid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Humma Shahid has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
John F Salmon
Oxford Eye Hospital, Oxford, UK
2 shared publicationsA Pearson
Royal Berkshire Hospital, Reading, UK
1 shared publicationA Sandhu
John Radcliffe Hospital, Headington, Oxford, UK
1 shared publicationAnthony T Moore
Institute of Ophthalmology, University College London and Moorfields Eye Hospital, London, UK
1 shared publicationBaljinder K Matharu
Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK
1 shared publicationCambridge Addenbrookes Hospital
1 shared publication
Latest Publications
- 1 January 2013
- Published by Touch Medical Media, Ltd. in European Ophthalmic Review
- Vol. 07 (01)
The Effectiveness of Trans-scleral Cyclodiode Treatment
Transcleral cyclodiode laser treatment is increasingly being used in the management of complex glaucoma. This review discusses the literature with reference to the effectiveness of this treatment modality as well as its potential limitations.
- 1 January 2013
- Published by Touch Medical Media, Ltd. in European Ophthalmic Review
- Vol. 07 (01)
The Effectiveness of Trans-scleral Cyclodiode Treatment
Transcleral cyclodiode laser treatment is increasingly being used in the management of complex glaucoma. This review discusses the literature with reference to the effectiveness of this treatment modality as well as its potential limitations.
- 10 November 2012
- Published by BMJ in British Journal of Ophthalmology
- Vol. 97 (2) , 235-236
Fifteen-year mortality rate and visual outcome in newly diagnosed chronic open-angle glaucoma
- 10 November 2012
- Published by BMJ in British Journal of Ophthalmology
- Vol. 97 (2) , 235-236
Fifteen-year mortality rate and visual outcome in newly diagnosed chronic open-angle glaucoma
- Open Access
- 1 May 2012
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 40 (4) , 339-340
The changing geometry of angle closure
- 1 May 2012
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 40 (4) , 339-340
Open AccessThe changing geometry of angle closure
- Open Access
- 27 March 2012
- Published by Hindawi Limited in Journal of Ophthalmology
- Vol. 2012, 1-6
Malignant Glaucoma: A Review of the Modern Literature
Malignant glaucoma is a rare form of glaucoma that typically follows surgery in patients with primary angle closure and primary angle-closure glaucoma. In this paper, the clinical features, classification, pathogenesis, and principles of management are discussed. Despite a high prevalence of primary angle closure glaucoma in South-East Asia, the vast majority of cases of malignant glaucoma are reported in White populations. This may reflect differing mechanisms of angle closure in White and Asian patients, which somehow reduces the likelihood of an aberrant relationship developing between the lens, ciliary body, anterior hyaloid, and vitreous structures within the eye. Although the exact underlying pathogenic mechanism remains unclear, the prognosis is good with modern medical, laser, and surgical treatment modalities.
- 27 March 2012
- Published by Hindawi Limited in Journal of Ophthalmology
- Vol. 2012, 1-6
Open AccessMalignant Glaucoma: A Review of the Modern Literature
Malignant glaucoma is a rare form of glaucoma that typically follows surgery in patients with primary angle closure and primary angle-closure glaucoma. In this paper, the clinical features, classification, pathogenesis, and principles of management are discussed. Despite a high prevalence of primary angle closure glaucoma in South-East Asia, the vast majority of cases of malignant glaucoma are reported in White populations. This may reflect differing mechanisms of angle closure in White and Asian patients, which somehow reduces the likelihood of an aberrant relationship developing between the lens, ciliary body, anterior hyaloid, and vitreous structures within the eye. Although the exact underlying pathogenic mechanism remains unclear, the prognosis is good with modern medical, laser, and surgical treatment modalities.
- 23 August 2011
- Published by BMJ in British Journal of Ophthalmology
- Vol. 96 (3) , 427-431
Age-related macular degeneration: the importance of family history as a risk factor
Background Family history is considered a risk factor for age-related macular degeneration (AMD). With the advent of effective therapy for the disease, the importance of family history merits further investigation. This study quantifies the risk associated with family history, first, by a case–control study of reported family history and, second, by examining the siblings of AMD cases. Methods The authors recruited cases with advanced AMD, spouses and siblings. All subjects were carefully phenotyped. Clinical findings in the siblings were compared with spouses. Information about family history was collected. The ORs for reported family history of AMD were calculated. Analyses were adjusted for age, smoking and genotype. Results 495 AMD cases, 259 spouses and 171 siblings were recruited. The OR for AMD was 27.8 (CI 3.8 to 203.0; p=0.001) with a reported family history of an affected parent and 12.0 (CI 3.7 to 38.6; pConclusion The risk of AMD is greatly increased by having an affected first-degree relative. Those at risk need to be made aware of this and AMD patients should advise siblings and children to seek prompt ophthalmological advice if they develop visual symptoms of distortion or reduced vision.
- 23 August 2011
- Published by BMJ in British Journal of Ophthalmology
- Vol. 96 (3) , 427-431
Age-related macular degeneration: the importance of family history as a risk factor
Background Family history is considered a risk factor for age-related macular degeneration (AMD). With the advent of effective therapy for the disease, the importance of family history merits further investigation. This study quantifies the risk associated with family history, first, by a case–control study of reported family history and, second, by examining the siblings of AMD cases. Methods The authors recruited cases with advanced AMD, spouses and siblings. All subjects were carefully phenotyped. Clinical findings in the siblings were compared with spouses. Information about family history was collected. The ORs for reported family history of AMD were calculated. Analyses were adjusted for age, smoking and genotype. Results 495 AMD cases, 259 spouses and 171 siblings were recruited. The OR for AMD was 27.8 (CI 3.8 to 203.0; p=0.001) with a reported family history of an affected parent and 12.0 (CI 3.7 to 38.6; pConclusion The risk of AMD is greatly increased by having an affected first-degree relative. Those at risk need to be made aware of this and AMD patients should advise siblings and children to seek prompt ophthalmological advice if they develop visual symptoms of distortion or reduced vision.
- 1 February 2010
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 26 (1) , 119-124
Use of 5-Fluorouracil Injections to Reduce the Risk of Trabeculectomy Bleb Failure After Cataract Surgery
To determine whether the use of postoperative subconjunctival 5-fluorouracil (5-FU) reduces the risk of trabeculectomy bleb failure after uncomplicated small incisional cataract surgery. Twenty-five consecutive patients with primary open-angle glaucoma and a functioning trabeculectomy bleb and who underwent uncomplicated phacoemulsification surgery were given subconjunctival injections of 5 mg 5-FU at 2, 4, and 12 weeks after cataract surgery (5-FU group). The mean postoperative intraocular pressure (IOP) over a 2-year period and the trabeculectomy survival rate, as determined by Kaplan-Meier survival analysis, was compared with a historical series of patients who had undergone cataract surgery in the presence of a filtering trabeculectomy bleb, but who had not received 5-FU (control group). After a 2-year follow-up period, there was no significant difference in the mean IOP between the 5-FU (15.1 mm Hg SD 3.1) and control (15.3 mm Hg SD 3.3) groups (P = 0.67). An IOP > 21 mm Hg at any time point after the first postoperative month after cataract surgery was found in 4.0% cases in the 5-FU group and 16.7% cases in the control group (P = 0.78). Using Kaplan-Meier survival analysis, the difference in the cumulative probability of survival between the 5-FU and control groups was not significant (P = 0.30). Cataract surgery is a significant risk factor for trabeculectomy bleb failure. The use of subconjunctival 5-FU injections at 2, 4, and 12 weeks after cataract surgery in elderly white patients with primary open-angle glaucoma does not reduce the risk of trabeculectomy failure.
- 1 February 2010
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 26 (1) , 119-124
Use of 5-Fluorouracil Injections to Reduce the Risk of Trabeculectomy Bleb Failure After Cataract Surgery
To determine whether the use of postoperative subconjunctival 5-fluorouracil (5-FU) reduces the risk of trabeculectomy bleb failure after uncomplicated small incisional cataract surgery. Twenty-five consecutive patients with primary open-angle glaucoma and a functioning trabeculectomy bleb and who underwent uncomplicated phacoemulsification surgery were given subconjunctival injections of 5 mg 5-FU at 2, 4, and 12 weeks after cataract surgery (5-FU group). The mean postoperative intraocular pressure (IOP) over a 2-year period and the trabeculectomy survival rate, as determined by Kaplan-Meier survival analysis, was compared with a historical series of patients who had undergone cataract surgery in the presence of a filtering trabeculectomy bleb, but who had not received 5-FU (control group). After a 2-year follow-up period, there was no significant difference in the mean IOP between the 5-FU (15.1 mm Hg SD 3.1) and control (15.3 mm Hg SD 3.3) groups (P = 0.67). An IOP > 21 mm Hg at any time point after the first postoperative month after cataract surgery was found in 4.0% cases in the 5-FU group and 16.7% cases in the control group (P = 0.78). Using Kaplan-Meier survival analysis, the difference in the cumulative probability of survival between the 5-FU and control groups was not significant (P = 0.30). Cataract surgery is a significant risk factor for trabeculectomy bleb failure. The use of subconjunctival 5-FU injections at 2, 4, and 12 weeks after cataract surgery in elderly white patients with primary open-angle glaucoma does not reduce the risk of trabeculectomy failure.
- Open Access
- 29 January 2010
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 4 (1) , 27
Anaphylactic response to topical fluorescein 2% eye drops: a case report
The intravenous use of fluorescein 10% during retinal angiography can cause severe systemic reactions including, on rare occasions, anaphylaxis. Fluorescein 2% eye drops are used extensively for clinical examination and diagnosis, but to the best of our knowledge, they have only been reported as being responsible for a systemic anaphylactic response on two previous occasions.
- 29 January 2010
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 4 (1) , 27
Open AccessAnaphylactic response to topical fluorescein 2% eye drops: a case report
The intravenous use of fluorescein 10% during retinal angiography can cause severe systemic reactions including, on rare occasions, anaphylaxis. Fluorescein 2% eye drops are used extensively for clinical examination and diagnosis, but to the best of our knowledge, they have only been reported as being responsible for a systemic anaphylactic response on two previous occasions.
- 11 September 2008
- Published by BMJ in British Journal of Ophthalmology
- Vol. 92 (12) , 1689-1692
Factors affecting outcome of punctoplasty surgery: a review of 205 cases
Aim: We reviewed retrospectively the indications, surgical techniques and outcomes of punctoplasty surgery for 205 consecutive patients in order to identify factors that influence success. Methods: We identified all patients who underwent punctoplasty surgery from April 2002 to June 2006 within the Royal Berkshire NHS Trust, UK. No patient had an additional procedure simultaneously. Hospital records were used to ascertain the proportion of patients who were appropriately assessed preoperatively, the anatomical and functional success rates for surgery and the patient satisfaction rate. We assessed the influence of surgical technique, grade of operating surgeon and the use of postoperative topical medication on these outcomes. Results: Eighty-two per cent of patients had an appropriate preoperative assessment. Amongst these, the anatomical and functional success rates for punctoplasty surgery were 91% and 64%, respectively. The patient satisfaction rate was 71%. The grade of surgeon did not significantly affect outcome of punctoplasty (p = 0.4). The use of topical steroids postoperatively did not significantly improve surgical outcome (p = 0.7). There was no significant difference in anatomical success between a two-snip versus a three-snip punctoplasty technique (p = 0.7). However, in the presence of anatomical success the two-snip procedure gave significantly greater functional success (p = 0.03). Conclusions: This is the largest reported consecutive case series of isolated punctoplasty surgery. Overall anatomical success was high and the surgical technique, grade of surgeon and choice of postoperative medication did not significantly alter the outcome. Without adequate preoperative assessment a significant proportion of patients may undergo surgery inappropriately. Even with an adequate assessment anatomical success is not always followed by resolution of epiphora.
- 11 September 2008
- Published by BMJ in British Journal of Ophthalmology
- Vol. 92 (12) , 1689-1692
Factors affecting outcome of punctoplasty surgery: a review of 205 cases
Aim: We reviewed retrospectively the indications, surgical techniques and outcomes of punctoplasty surgery for 205 consecutive patients in order to identify factors that influence success. Methods: We identified all patients who underwent punctoplasty surgery from April 2002 to June 2006 within the Royal Berkshire NHS Trust, UK. No patient had an additional procedure simultaneously. Hospital records were used to ascertain the proportion of patients who were appropriately assessed preoperatively, the anatomical and functional success rates for surgery and the patient satisfaction rate. We assessed the influence of surgical technique, grade of operating surgeon and the use of postoperative topical medication on these outcomes. Results: Eighty-two per cent of patients had an appropriate preoperative assessment. Amongst these, the anatomical and functional success rates for punctoplasty surgery were 91% and 64%, respectively. The patient satisfaction rate was 71%. The grade of surgeon did not significantly affect outcome of punctoplasty (p = 0.4). The use of topical steroids postoperatively did not significantly improve surgical outcome (p = 0.7). There was no significant difference in anatomical success between a two-snip versus a three-snip punctoplasty technique (p = 0.7). However, in the presence of anatomical success the two-snip procedure gave significantly greater functional success (p = 0.03). Conclusions: This is the largest reported consecutive case series of isolated punctoplasty surgery. Overall anatomical success was high and the surgical technique, grade of surgeon and choice of postoperative medication did not significantly alter the outcome. Without adequate preoperative assessment a significant proportion of patients may undergo surgery inappropriately. Even with an adequate assessment anatomical success is not always followed by resolution of epiphora.